| id | C00002969 |
|---|---|
| Name | Norlichexanthone |
| CAS RN | 20716-98-7 |
| Standard InChI | InChI=1S/C14H10O5/c1-6-2-7(15)4-10-12(6)14(18)13-9(17)3-8(16)5-11(13)19-10/h2-5,15-17H,1H3 |
| Standard InChI (Main Layer) | InChI=1S/C14H10O5/c1-6-2-7(15)4-10-12(6)14(18)13-9(17)3-8(16)5-11(13)19-10/h2-5,15-17H,1H3 |
| Phytochemical cluster | No. 15 |
|---|---|
| KCF-S cluster | No. 71 |
| By standard InChI | CHEMBL466154 |
|---|---|
| By standard InChI Main Layer | CHEMBL466154 |
| By LinkDB | C10087 |
|---|
| By CAS RN |
|---|
| class name | count |
|---|
| family name | count |
|---|---|
| Lecanoraceae | 1 |
| KNApSAcK organism | *ID | *family | *plant class | *kingdom |
|---|---|---|---|---|
| Lecanora iseana | ||||
| Lecanora reuteri | 108948 | Lecanoraceae | Fungi |
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| Q02750 | Dual specificity mitogen-activated protein kinase kinase 1 | Ste7 | CHEMBL466154 |
CHEMBL1816869
(1)
|
1 / 1 |
| P08069 | Insulin-like growth factor 1 receptor | TK tyrosine-protein kinase INSR subfamily | CHEMBL466154 |
CHEMBL1816868
(1)
|
1 / 3 |
| Q16512 | Serine/threonine-protein kinase N1 | Pkn | CHEMBL466154 |
CHEMBL1816875
(1)
|
0 / 0 |
| P11309 | Serine/threonine-protein kinase pim-1 | Pim | CHEMBL466154 |
CHEMBL1816873
(1)
|
0 / 0 |
| Q05397 | Focal adhesion kinase 1 | Fak | CHEMBL466154 |
CHEMBL1816867
(1)
|
0 / 0 |
| P51955 | Serine/threonine-protein kinase Nek2 | Nek | CHEMBL466154 |
CHEMBL1816871
(1)
|
0 / 0 |
| Q9UM73 | ALK tyrosine kinase receptor | TKL serine/threonine protein kinase STKR type 1 subfamily | CHEMBL466154 |
CHEMBL1816863
(1)
|
1 / 1 |
| O60285 | NUAK family SNF1-like kinase 1 | CAMK serine/threonine protein kinase NUAK subfamily | CHEMBL466154 |
CHEMBL1816864
(1)
|
0 / 0 |
| P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | CHEMBL466154 |
CHEMBL1816876
(1)
|
0 / 0 |
| Q96GD4 | Aurora kinase B | Aur | CHEMBL466154 |
CHEMBL1816865
(1)
|
0 / 0 |
| P35968 | Vascular endothelial growth factor receptor 2 | Vegfr | CHEMBL466154 |
CHEMBL1816877
(1)
|
1 / 0 |
| P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | CHEMBL466154 |
CHEMBL1816870
(1)
|
2 / 3 |
| P53350 | Serine/threonine-protein kinase PLK1 | PLK serine/threonine protein kinase subfamily | CHEMBL466154 |
CHEMBL1816874
(1)
|
0 / 0 |
| P31749 | RAC-alpha serine/threonine-protein kinase | Akt | CHEMBL466154 |
CHEMBL1816862
(1)
|
4 / 1 |
| Q9HC98 | Serine/threonine-protein kinase Nek6 | Nek | CHEMBL466154 |
CHEMBL1816872
(1)
|
0 / 0 |
| P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL466154 |
CHEMBL985773
(1)
|
0 / 1 |
| P30530 | Tyrosine-protein kinase receptor UFO | TK tyrosine-protein kinase AXL subfamily | CHEMBL466154 |
CHEMBL1816866
(1)
|
0 / 0 |
| OMIM | preferred title | UniProt |
|---|---|---|
| #114480 | Breast cancer |
P31749
|
| #615279 | Cardiofaciocutaneous syndrome 3; cfc3 |
Q02750
|
| #114500 | Colorectal cancer; crc |
P31749
|
| #615109 | Cowden syndrome 6; cws6 |
P31749
|
| #602089 | Hemangioma, capillary infantile |
P35968
|
| #114550 | Hepatocellular carcinoma |
P08581
|
| #270450 | Insulin-like growth factor i, resistance to |
P08069
|
| #613014 | Neuroblastoma, susceptibility to, 3; nblst3 |
Q9UM73
|
| #176920 | Proteus syndrome |
P31749
|
| #605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
| KEGG | disease name | UniProt |
|---|---|---|
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00015 | Malignant pleural mesothelioma |
P08069
(related)
|
| H00050 | Synovial sarcoma |
P08069
(related)
|
| H01274 | Growth delay due to insulin-like growth factor I resistance |
P08069
(related)
|
| H00018 | Gastric cancer |
P08581
(related)
|
| H00021 | Renal cell carcinoma |
P08581
(related)
|
| H00046 | Cholangiocarcinoma |
P08581
(related)
|
| H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
| H00523 | Noonan syndrome and related disorders |
Q02750
(related)
|
| H00014 | Non-small cell lung cancer |
Q9UM73
(related)
|